Medical Research
(H12)
IRS Verified
DX Registered
990 on File
RARE DISEASE RENEGADES A NJ NONPROFIT CORPORATION
Financial strength (30%)
43/100
Reliability (20%)
45/100
Effectiveness (25%)
43/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$12K
Total Revenue
$101K
Total Expenses
$50K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
10.7%
Fundraising Efficiency
N/A
Operating Reserve
5.96x
Liability-to-Asset
0.0%
Revenue Diversification
186.4%
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
10.7% | 84.5% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
6.0 mo | 13.4 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.4% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
186.4% | 93.3% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-86.9% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
3160.7% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-761.6% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $12K | $101K | $50K | 10.7% | — |
| 2023 | $89K | $3K | $139K | 240.5% | — |
| 2022 | $105K | $53K | $53K | 32.1% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.